TP53 and ovarian carcinoma: Our findings indicate that p53 mediated cell-cycle-arrest/DNA repair serves as a barrier to optimal chemotherapeutic treatment of ovarian and perhaps other carcinomas and suggest that inhibition of p53 during chemotherapy may enhance the long-term survivorship of ovarian cancer patients.